Axsome Therapeutics Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Axsome Therapeutics Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- AXSM
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001579428
Board of directors
-
Herriot Tabuteau · Director · Chief Executive OfficerSince 2023
-
Mark Coleman · DirectorSince 2023
-
Mark E. Saad · DirectorSince 2023
-
Roger Jeffs · DirectorSince 2023
-
Susan Mahony · DirectorSince 2023
Chief executives
Herriot Tabuteau
· CHIEF EXECUTIVE OFFICER
Dates unknown
Board connections
2 of this board's directors also sit on 3 other boards.
- via Susan Mahony
- via Roger Jeffs
- via Susan Mahony
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $137,660,944
- 35 sales by 8 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 6, 2026 | Herriot Tabuteau Director, Officer (Chief Executive Officer), 10% owner | Option exercise | +4,660 | $4.95 | $23,067 |
| Aug 6, 2026 | Herriot Tabuteau Director, Officer (Chief Executive Officer), 10% owner | Open-market sale | −4,660 | $213.95 | $997,007 |
| Aug 5, 2026 | Herriot Tabuteau Director, Officer (Chief Executive Officer), 10% owner | Option exercise | +45,004 | $4.95 | $222,770 |
| Aug 5, 2026 | Herriot Tabuteau Director, Officer (Chief Executive Officer), 10% owner | Open-market sale | −45,004 | $212.01 | $9,541,298 |
| Jul 1, 2026 | Herriot Tabuteau Director, Officer (Chief Executive Officer), 10% owner | Option exercise | +49,666 | $4.95 | $245,847 |
| Jul 1, 2026 | Herriot Tabuteau Director, Officer (Chief Executive Officer), 10% owner | Open-market sale | −49,666 | $240.25 | $11,932,257 |
| Jun 11, 2026 | Roger Jeffs Director | Open-market sale | −286 | $249.12 | $71,248 |
| Jun 10, 2026 | Roger Jeffs Director | Open-market sale | −286 | $246.18 | $70,407 |
| Jun 10, 2026 | Mark Coleman Director | Open-market sale | −643 | $249.00 | $160,107 |
| Jun 10, 2026 | Susan Mahony Director | Open-market sale | −300 | $246.18 | $73,854 |
| Jun 9, 2026 | Herriot Tabuteau Director, Officer (Chief Executive Officer), 10% owner | Option exercise | +49,670 | $4.95 | $245,867 |
| Jun 9, 2026 | Pizzie Nick Officer (Chief Financial Officer) | Option exercise | +33,000 | $3.50 | $115,500 |
| Jun 9, 2026 | Susan Mahony Director | Open-market sale | −300 | $237.21 | $71,163 |
| Jun 9, 2026 | Herriot Tabuteau Director, Officer (Chief Executive Officer), 10% owner | Open-market sale | −49,670 | $241.01 | $11,970,967 |
| Jun 9, 2026 | Pizzie Nick Officer (Chief Financial Officer) | Open-market sale | −33,000 | $240.09 | $7,922,970 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.